Yahoo Web Search

  1. This means that investors who seek to profit from falling equity prices are currently targeting MNK.

  2. Supernus' ADHD Candidate Positive in 4th Phase III Study

    Zacks via Yahoo FinanceApr 01 20:46 PM

    Data from the study was consistent with the first three studies. Patients who received the 400 mg dose of SPN-812 daily, demonstrated a statistically significant improvement in ADHD rating scale ...

  3. A physician ally of Purdue Pharma LP whose views helped drive the explosive growth in the use of addictive pain relievers for common aches and pains in the United States has agreed to testify ...

  4. Comeback Gives S&P an 8-Session Winning Streak

    Zacks via Yahoo FinanceApr 09 13:15 PM

    Kevin Matras, Kevin Cook, Dr. John Blank and Sheraz Mian will cover the investment landscape from several angles in this informative event. Read the full write-up for a lot more on COST.

  5. Mallinckrodt plc MNK announced that Stratatech (acquired in 2016) has completed enrollment in the phase III study on its investigational regenerative skin tissue, StrataGraft.